Nanovibronix Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The firm's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
Follow-Up Questions
Who is the CEO of Nanovibronix Inc?
Dr. Doron Besser is the Chief Executive Officer of Nanovibronix Inc, joining the firm since 2025.
What is the price performance of NAOV stock?
The current price of NAOV is $4.95, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Nanovibronix Inc?
Nanovibronix Inc belongs to Health Care industry and the sector is Health Care
